What is the best pharmacotherapeutic strategy for HER-2 positive breast cancer?

Amplification of the human epidermal growth factor receptor 2 (HER2) oncogene occurs in about 15% of newly diagnosed, operable breast cancer, and in about 20% of patients with advanced breast cance...